All lobbying filings

CROSSROADS STRATEGIES, LLC

Lobbying for ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) · medical technology association

Filing 1st Quarter - Report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 19, 2026

Income

$50,000.00

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Lobbyists on this filing 1

LUCIA PANZA New on this filing

Previously held: Counsel, U.S. Senator Charles E. Schumer; Counsel, U.S. Senate Judiciary Committee; Legislative Assistant, U.S. Senator Barbara Boxer; Law Clerk, Senate Health, Education, Labor & Pensions Committee; Law Clerk, Senate Judiciary Committee

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 3

Centers For Medicare and Medicaid Services (CMS)
HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 2

HR 5343
Ensuring Patient Access to Critical Breakthrough Products Act
HR 7148
Consolidated Appropriations Act, 2026

Lobbying activity 5

Health Issues

General education to advance policies that support innovation in the medical device industry. Issues related to coverage and reimbursement of diagnostic tests, including Issues related to FDA regulation of medical devices. Issues related to medical device sterilization. Policy issues related to the regulation of artificial intelligence for medical technology. Policies that could impact supply chain for medical technology. H.R.5343, Ensuring Patient Access to Critical Breakthrough Products Act.

Medicare/Medicaid

General education to advance policies that support innovation in the medical device industry. Issues related to the coverage and reimbursement of medical devices and technology, including AI. H.R.5343, Ensuring Patient Access to Critical Breakthrough Products Act.

Trade (domestic/foreign)

Policies impacting the supply chain and manufacturing of medical devices and technology including tariffs. Issues related to reimbursement in Japan.

Budget/Appropriations

Discussions regarding implementation of medtech related provisions for FY26 and FY27; H.R.7148, Making further consolidated appropriations for the fiscal year ending September 30, 2026, and for other purposes (P.L.119-75); FY2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations.

Defense

Policies impacting third party repair of medtech. Issues related to competitive bidding in the NDAA.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.